Related Experiment Video
Updated: Jul 29, 2025

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
Systematic Microbiome Dysbiosis Is Associated with IgA Nephropathy
Fengtao Cai1,2, Chenfen Zhou3, Na Jiao4
1School of Medicine, South China University of Technology, Guangzhou, China.
IgA nephropathy (IgAN) is linked to microbial imbalances across oral, gut, and urinary tracts. Specific bacteria may serve as noninvasive biomarkers for diagnosing IgAN.
Area of Science:
- Microbiology
- Nephrology
- Genomics
Background:
- IgA nephropathy (IgAN) is associated with microbial dysbiosis.
- The microbiome's role in IgAN across multiple body sites is not fully understood.
Purpose of the Study:
- To systematically investigate microbial dysbiosis in IgAN patients across various niches.
- To identify potential microbial biomarkers for IgAN diagnosis.
Main Methods:
- Large-scale 16S rRNA gene sequencing was performed on 1,732 samples (oral, pharynx, gut, urine) from IgAN patients and healthy controls.
- Microbial abundance data were analyzed to identify differences between groups and correlations with disease markers.
- Random forest classifiers were developed to predict IgAN status.
Main Results:
- Niche-specific increases in opportunistic pathogens (e.g., Bergeyella, Capnocytophaga) and decreases in beneficial commensals were observed in IgAN patients.
- Similar microbial alterations were noted between early and advanced chronic kidney disease (CKD) stages.
- Oral and pharyngeal bacteria (Bergeyella, Capnocytophaga, Comamonas) correlated positively with creatinine and urea levels.
- Random forest models achieved high accuracy (0.879 discovery, 0.780 validation) in predicting IgAN.
Conclusions:
- This study provides comprehensive microbial profiles of IgAN across multiple body sites.
- Identified microbial signatures show potential as noninvasive biomarkers for IgAN detection and clinical application.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Nephrotic Syndrome I : Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

